Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Diovan Generic Launched by Mylan
Yahoo/Zacks
Monday, September 24, 2012 - 5:57pm
tags:
Mylan, Diovan, generics, Novartis, antihypertensives
Will Abbott's Magic Pill Send Stock Soaring?
Seeking Alpha
Monday, September 24, 2012 - 5:56pm
tags:
Abbott Labs, testosterone, Androgel
Drug-Trial Operator Quintiles Said to Study Initial Offering
Bloomberg
Monday, September 24, 2012 - 12:16pm
tags:
Quintiles, IPO
Pfizer: Here’s How We are Combating Generic Drugs
Wall St. Cheat Sheet
Monday, September 24, 2012 - 12:14pm
tags:
generics, Pfizer, Eliquis, Bristol-Myers Squibb
Valeant buys Visudyne drug from QLT; QLT stock jumps
Reuters
Monday, September 24, 2012 - 11:20am
tags:
Valeant Pharmaceuticals, Visudyne, QLT, age-related macular degeneration
3 Pharmaceuticals Pursuing Non-Surgical Approaches To Combating Cancer
Seeking Alpha
Monday, September 24, 2012 - 11:18am
tags:
OncoSec, Celsion, AngioDynamics, Bristol-Myers Squibb, cancer
The Promising, Cheap, And Growing Cell Therapy Arena Continues To Outperform The Market
Seeking Alpha
Monday, September 24, 2012 - 11:17am
tags:
Neuralstem, NeoStem, Osiris, Pluristem, stem cells, StemCells
Peregrine Pharma Stock Craters on Lung Cancer Drug Blowup
TheStreet.com
Monday, September 24, 2012 - 11:08am
tags:
Peregrine Pharmaceuticals, lung cancer, bavituximab
European Medicines Agency has recommendations for Novartis, Pfizer, Bristol-Myers Squibb and others
Pharma Times, UK
Monday, September 24, 2012 - 11:07am
tags:
Pfizer, Bristol-Myers Squibb, Eliquis, stroke, IBS, Almirall, Novartis, Europe
Roche $5.7 Billion Tumor Drug Sales Hinge on Rival Tests
Bloomberg
Monday, September 24, 2012 - 11:04am
tags:
Roche, cancer, Herceptin
Questcor reveals U.S. government investigation, shares dive
Reuters
Monday, September 24, 2012 - 10:35am
tags:
Questcor, Acthar, generics
Cellceutix to Commence Clinical Trials for Its Novel Anti-Cancer Drug Kevetrin
Yahoo
Monday, September 24, 2012 - 10:32am
tags:
Cellceutix, Kevetrin, small molecule drugs
Spectrum Pharma Not Ready to Call Lymphoma Study a Win
TheStreet.com
Monday, September 24, 2012 - 10:30am
tags:
Spectrum Pharmaceuticals, lymphoma, belinostat, TopoTarget, peripheral T-cell lymphoma
Galderma and NovaBay Enroll First Patients in Phase 2b Clinical Study of NVC-422 for Impetigo
Yahoo
Monday, September 24, 2012 - 10:23am
tags:
Galderma, NovaBay, NVC-422, impetigo
A New Reason to be Bullish About Sarepta Therapeutics
TheStreet.com
Monday, September 24, 2012 - 10:22am
tags:
Sarepta Therapeutics, eteplirsen, Duchenne Muscular Dystrophy
Novartis: RLX030 reduced deaths in patients with acute heart failure
Yahoo/Fly on the Wall
Monday, September 24, 2012 - 10:21am
tags:
RLX030, heart failure, Novartis, serelaxin
R&D and launch of new generic drugs to up US biz: Wockhardt
CNBC
Sunday, September 23, 2012 - 12:55pm
tags:
Wockhardt
Are Staph Infection Vaccines on the Cusp?
Wall Street Cheat Street
Sunday, September 23, 2012 - 12:53pm
tags:
Pfizer, NovaDigm Therapeutics, GSK, MRSA, staph infection, vaccines
Big Pharma Faces its China Moment
Motley Fool
Sunday, September 23, 2012 - 12:52pm
tags:
A Primer on the Health-Care Sector
Motley Fool
Sunday, September 23, 2012 - 12:50pm
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.